EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
94 hedge funds and large institutions have $252M invested in Eiger BioPharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
+9
Holders Change %
+10.59%
% of All Funds
1.49%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
20
Increased
28
Reduced
29
Closed
11
Calls
$2.99M
Puts
$577K
Net Calls
+$2.41M
Net Calls Change
+$2.37M
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
$14.1M |
| 2 |
VA
VR Adviser
New York
|
$12.2M |
| 3 |
Morgan Stanley
New York
|
$11.8M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
$6.5M |
| 5 |
Barclays
London,
United Kingdom
|
$4.19M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TI
101
Trexquant Investment
Stamford,
Connecticut
| – | -$94K | -602 | Closed |
|
|
ECM
102
ExodusPoint Capital Management
New York
| – | -$69K | -442 | Closed |
|
103
ProShare Advisors
Bethesda,
Maryland
| – | -$62K | -393 | Closed |
|
104
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$22K | -144 | Closed |
|